Učitavanje...
Risks vs Benefits for SGLT2 Inhibitor Medications
Health care providers should carefully assess patients with diabetes mellitus before prescribing sodium-glucose cotransporter 2 inhibitor medications and monitor for adverse effects.
Spremljeno u:
| Izdano u: | Fed Pract |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontline Medical Communications Inc.
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6368009/ https://ncbi.nlm.nih.gov/pubmed/30766374 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|